Ticagrelor was associated with lifetime quality-adjusted life-year ( QALY ) gains of @ in Sweden , @ in the UK , @ in Germany and @ in Brazil compared with generic clopidogrel , with increased healthcare costs of @ , @ , @ and @ , respectively .